FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to biotechnology and represents application of peptide with SEQ ID NO:1 or SEQ ID NO:2 or their fragments, including fragments with amidation in position p11 and fragments with acetilation in position p1and amidation in position p11, for preparation of pharmaceutical composition for cancer treatment. In addition, said peptides are applied after immunisation for protection against tumour growth.
EFFECT: peptides are applied in mixture for immunisation with agent for inhibition of humoral immune response, for stimulation of antigen-presenting cells, as well as ajuvant in vaccination.
6 cl, 16 dwg, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA | 2006 |
|
RU2430738C2 |
| CONJUGATES FOR ADMINISTERING BIOLOGICALLY ACTIVE COMPOUNDS | 2009 |
|
RU2567667C2 |
| IMMUNOSTIMULATING COMBINATION FOR PREVENTION AND TREATMENT OF HEPATITIS C | 2006 |
|
RU2431499C2 |
| PEPTIDES HAVING CAPACITY TO BIND WITH SCURFIN AND USE THEREOF | 2008 |
|
RU2502741C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
| ANTI-ICOS ANTIBODIES | 2017 |
|
RU2764548C2 |
| PEPTIDE CAPABLE OF BINDING WITH β AND INHIBITING BIOLOGICAL ACTIVITY OF β IN VITRO AND/OR IN VIVO, APPLICATION OF PEPTIDE, PHARMACEUTICAL COMPOSITION, DNA SEQUENCE, DNA STRUCTURE, EXPRESSION VECTOR, HOST-CELL AND METHOD OF OBTAINING PEPTIDE | 2004 |
|
RU2333917C2 |
| USE OF DNA SEQUENCE WHICH CODES PEPTIDE ABLE TO BIND WITH TRANSFORMING GROWTH FACTOR β1 (VERSIONS) | 2008 |
|
RU2455358C2 |
| PROSTATE-ASSOCIATED ANTIGENS AND IMMUNOTHERAPEUTIC REGIMENS BASED ON VACCINES | 2013 |
|
RU2737765C2 |
| RECOMBINANT CHIMERIC PROTEIN ANTH1, NUCLEIC ACID ENCODING ITS AND THEIR USING | 2003 |
|
RU2322455C2 |
